US lawmakers killed a proposal targeting science efforts with China, and did this instead

The US Congress passed its annual defence bill on Wednesday, easing concerns among researchers by dropping a controversial proposal targeting US-China scientific collaboration, even as it imposed new restrictions on Chinese biotechnology companies.

The SAFE (Securing American Funding and Expertise from Adversarial Research Exploitation) Research Act would have denied federal funding to any US researcher working with scientists from China and several other countries, but it did not make it into the US$901 billion National Defence Authorisation Act for the 2026 financial year.

The proposal, introduced by Michigan Republican Representative John Moolenaar, was widely criticised by the US research community, including senior academics and major scientific organisations.

Lin Haifan, a cell biologist at Yale University, told Science magazine that such a measure could “accelerate the breakdown of the people-to-people trust” that was key to scientific collaboration.

“Without this kind of positive energy, the US and China will become more and more polarised and eventually become each other’s enemy,” he said last month.

In an October 29 open letter led by Stanford physicists Steven Kivelson and Peter Michelson, more than 750 scholars and researchers said the United States must foster collaboration and attract global talent to maintain its research competitiveness and leadership.

“Unfortunately, provisions of the SAFE Research Act, while perhaps well intended, will hurt our ability to do this,” said the letter, which was signed by Nobel laureates, including former US energy secretary Steven Chu and chemist William Moerner.

  

​Read More